SIM
KBIO

SSI Investment Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

SSI Investment Management’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-44,149
Closed -$612K – 387
2014
Q4 		$612K Sell
44,149
-906
-2% -$12.9K 0.06% 199
2014
Q3 		$561K Buy
45,055
+23,385
+108% +$322K 0.05% 212
2014
Q2 		$394K Buy
21,670
+12,436
+135% +$213K 0.04% 271
2014
Q1 		$200K Buy
+9,234
New +$268K 0.02% 379

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SSI Investment Management's KBIO Position: Q1 2015 in Review

SSI Investment Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 44,149 shares — an estimated $612K sold.

SSI Investment Management first reported a position in KBIO in Q1 2014 and held it in 4 quarters. The position peaked at $612K in Q4 2014. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

  • SSI Investment Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
  • SSI Investment Management sold 44,149 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $612K.
  • SSI Investment Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q1 2014 and held it in 4 quarters.
  • SSI Investment Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $612K in Q4 2014.
  • 24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on SSI Investment Management's 13F filing for Q1 2015, filed 12 May 2015.